erlotinib has been researched along with mangostin in 3 studies
Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (mangostin) | Trials (mangostin) | Recent Studies (post-2010) (mangostin) |
---|---|---|---|---|---|
221 | 0 | 180 | 435 | 3 | 352 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL | 1 |
Choowongkomon, K; Eurtivong, C; Jiwacharoenchai, N; Niwetmarin, W; Ruchirawat, S; Saruengkhanphasit, R; Seetaha, S | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for erlotinib and mangostin
Article | Year |
---|---|
Recent update on anti-dengue drug discovery.
Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication | 2019 |
2 other study(ies) available for erlotinib and mangostin
Article | Year |
---|---|
Discovery of potent antiproliferative agents from selected oxygen heterocycles as EGFR tyrosine kinase inhibitors from the U.S. National Cancer Institute database by in silico screening and bioactivity evaluation.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; ErbB Receptors; Heterocyclic Compounds; Humans; Molecular Docking Simulation; Molecular Structure; National Cancer Institute (U.S.); Oxygen; Protein Kinase Inhibitors; Structure-Activity Relationship; United States; Xanthenes | 2022 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |